忧郁 / 快感缺失型抑郁症临床评估与诊治指导建议

2021-01-30 中国精神科相关专家小组 临床精神医学杂志.2021,31(1):1-5.

忧郁/快感缺失型抑郁症是抑郁症的重要类型之一,临床表现以兴趣或愉快感缺失为主,其病理机制、治疗反应与非忧郁型抑郁症可能不同。本指导建议通过系统复习文献,为忧郁/快感缺失型抑郁症的评估、诊断和治疗提供循

中文标题:

忧郁 / 快感缺失型抑郁症临床评估与诊治指导建议

发布日期:

2021-01-30

简要介绍:

忧郁/快感缺失型抑郁症是抑郁症的重要类型之一,临床表现以兴趣或愉快感缺失为主,其病理机制、治疗反应与非忧郁型抑郁症可能不同。本指导建议通过系统复习文献,为忧郁/快感缺失型抑郁症的评估、诊断和治疗提供循证依据,其中治疗推荐是基于证据质量和临床专家共识。阿戈美拉汀、氟西汀、舍曲林、文拉法辛、度洛西汀、安非他酮、伏硫西汀和重复经颅磁刺激( 辅助治疗) 可以考虑作为忧郁/快感缺失型抑郁症患者治疗的一线推荐。

相关资料下载:
[AttachmentFileName(sort=1, fileName=忧郁_快感缺失型抑郁症临床评估与诊治指导建议_汪作为.pdf)] GetToolGuiderByIdResponse(projectId=1, id=8de081c0020ea303, title=忧郁 / 快感缺失型抑郁症临床评估与诊治指导建议, enTitle=, guiderFrom=临床精神医学杂志.2021,31(1):1-5., authorId=0, author=, summary=忧郁/快感缺失型抑郁症是抑郁症的重要类型之一,临床表现以兴趣或愉快感缺失为主,其病理机制、治疗反应与非忧郁型抑郁症可能不同。本指导建议通过系统复习文献,为忧郁/快感缺失型抑郁症的评估、诊断和治疗提供循, cover=https://img.medsci.cn/2021327/1616860564400_2020535.jpg, journalId=0, articlesId=null, associationId=812, associationName=中国精神科相关专家小组, associationIntro=null, copyright=0, guiderPublishedTime=Sat Jan 30 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p style="color: #373737;">忧郁/快感缺失型抑郁症是抑郁症的重要类型之一,临床表现以兴趣或愉快感缺失为主,其病理机制、治疗反应与非忧郁型抑郁症可能不同。本指导建议通过系统复习文献,为忧郁/快感缺失型抑郁症的评估、诊断和治疗提供循证依据,其中治疗推荐是基于证据质量和临床专家共识。阿戈美拉汀、氟西汀、舍曲林、文拉法辛、度洛西汀、安非他酮、伏硫西汀和重复经颅磁刺激( 辅助治疗) 可以考虑作为忧郁/快感缺失型抑郁症患者治疗的一线推荐。</p>, tagList=[TagDto(tagId=228, tagName=抑郁症)], categoryList=[CategoryDto(categoryId=13, categoryName=精神心理科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=228, guiderKeyword=抑郁症, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=12549, appHits=369, showAppHits=0, pcHits=1245, showPcHits=12180, likes=1, shares=28, comments=25, approvalStatus=1, publishedTime=Sun Mar 28 00:59:20 CST 2021, publishedTimeString=2021-01-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat Mar 27 23:56:25 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 20:20:25 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=忧郁_快感缺失型抑郁症临床评估与诊治指导建议_汪作为.pdf)])
忧郁_快感缺失型抑郁症临床评估与诊治指导建议_汪作为.pdf
下载请点击:
评论区 (20)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2099832, encodeId=5eef209983284, content=了解一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Fri Nov 11 10:41:30 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198798, encodeId=c59f1198e987d, content=参考一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048e6167235, createdName=ms1000001338777518, createdTime=Wed Mar 02 18:08:57 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184089, encodeId=9c35118408966, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd3c5395391, createdName=ms6000000839933699, createdTime=Fri Jan 14 00:25:59 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184088, encodeId=07b11184088ac, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd3c5395391, createdName=ms6000000839933699, createdTime=Fri Jan 14 00:25:37 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063006, encodeId=314a106300695, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/UJx7RTWzO1XeSJMHo1WPyXOeU950A6d2wpRE9fF0ZNrO3Rw8WXK3qF6nVCcAt2rJudmGVYibL988iat5nCQpYPYg/132, createdBy=1d1f5200812, createdName=ms1033071438812717, createdTime=Fri Oct 22 18:49:03 CST 2021, time=2021-10-22, status=1, ipAttribution=)]
    2022-11-11 ozzy

    了解一下

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2099832, encodeId=5eef209983284, content=了解一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Fri Nov 11 10:41:30 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198798, encodeId=c59f1198e987d, content=参考一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048e6167235, createdName=ms1000001338777518, createdTime=Wed Mar 02 18:08:57 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184089, encodeId=9c35118408966, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd3c5395391, createdName=ms6000000839933699, createdTime=Fri Jan 14 00:25:59 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184088, encodeId=07b11184088ac, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd3c5395391, createdName=ms6000000839933699, createdTime=Fri Jan 14 00:25:37 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063006, encodeId=314a106300695, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/UJx7RTWzO1XeSJMHo1WPyXOeU950A6d2wpRE9fF0ZNrO3Rw8WXK3qF6nVCcAt2rJudmGVYibL988iat5nCQpYPYg/132, createdBy=1d1f5200812, createdName=ms1033071438812717, createdTime=Fri Oct 22 18:49:03 CST 2021, time=2021-10-22, status=1, ipAttribution=)]
    2022-03-02 ms1000001338777518

    参考一下

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2099832, encodeId=5eef209983284, content=了解一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Fri Nov 11 10:41:30 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198798, encodeId=c59f1198e987d, content=参考一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048e6167235, createdName=ms1000001338777518, createdTime=Wed Mar 02 18:08:57 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184089, encodeId=9c35118408966, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd3c5395391, createdName=ms6000000839933699, createdTime=Fri Jan 14 00:25:59 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184088, encodeId=07b11184088ac, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd3c5395391, createdName=ms6000000839933699, createdTime=Fri Jan 14 00:25:37 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063006, encodeId=314a106300695, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/UJx7RTWzO1XeSJMHo1WPyXOeU950A6d2wpRE9fF0ZNrO3Rw8WXK3qF6nVCcAt2rJudmGVYibL988iat5nCQpYPYg/132, createdBy=1d1f5200812, createdName=ms1033071438812717, createdTime=Fri Oct 22 18:49:03 CST 2021, time=2021-10-22, status=1, ipAttribution=)]
    2022-01-14 ms6000000839933699

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2099832, encodeId=5eef209983284, content=了解一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Fri Nov 11 10:41:30 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198798, encodeId=c59f1198e987d, content=参考一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048e6167235, createdName=ms1000001338777518, createdTime=Wed Mar 02 18:08:57 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184089, encodeId=9c35118408966, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd3c5395391, createdName=ms6000000839933699, createdTime=Fri Jan 14 00:25:59 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184088, encodeId=07b11184088ac, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd3c5395391, createdName=ms6000000839933699, createdTime=Fri Jan 14 00:25:37 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063006, encodeId=314a106300695, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/UJx7RTWzO1XeSJMHo1WPyXOeU950A6d2wpRE9fF0ZNrO3Rw8WXK3qF6nVCcAt2rJudmGVYibL988iat5nCQpYPYg/132, createdBy=1d1f5200812, createdName=ms1033071438812717, createdTime=Fri Oct 22 18:49:03 CST 2021, time=2021-10-22, status=1, ipAttribution=)]
    2022-01-14 ms6000000839933699

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2099832, encodeId=5eef209983284, content=了解一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Fri Nov 11 10:41:30 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198798, encodeId=c59f1198e987d, content=参考一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048e6167235, createdName=ms1000001338777518, createdTime=Wed Mar 02 18:08:57 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184089, encodeId=9c35118408966, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd3c5395391, createdName=ms6000000839933699, createdTime=Fri Jan 14 00:25:59 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184088, encodeId=07b11184088ac, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd3c5395391, createdName=ms6000000839933699, createdTime=Fri Jan 14 00:25:37 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063006, encodeId=314a106300695, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/UJx7RTWzO1XeSJMHo1WPyXOeU950A6d2wpRE9fF0ZNrO3Rw8WXK3qF6nVCcAt2rJudmGVYibL988iat5nCQpYPYg/132, createdBy=1d1f5200812, createdName=ms1033071438812717, createdTime=Fri Oct 22 18:49:03 CST 2021, time=2021-10-22, status=1, ipAttribution=)]
    2021-10-22 ms1033071438812717

    学习

    0

拓展阅读

2016 CANMAT临床指南:成人抑郁症的管理

加拿大情绪和焦虑治疗网络(CANMAT,Canadian Network for Mood and Anxiety Treatments) · 2016-08-02

2016 ICSI卫生保健指南:抑郁症基层医疗管理(第17版)

临床系统改进协会(ICSI,Institute for Clinical Systems Improvement) · 2016-03-01

2016 EPA指南:慢性抑郁症的心理治疗

欧洲精神病学协会(EPA,European Psychiatric Association) · 2016-03-01

2016 USPSTF建议声明:儿童和青少年抑郁症筛查

美国预防医学工作组(USPSTF,U.S. Preventive Services Task Force) · 2016-02-09

2016 USPSTF建议声明:成人抑郁症筛查  

美国预防医学工作组(USPSTF,U.S. Preventive Services Task Force) · 2016-01-26